Overview
Description
VentriPoint Diagnostics Ltd. is an innovative medical technology company specializing in providing advanced diagnostic tools and solutions for the cardiovascular healthcare sector. The company's principal focus is on developing and commercializing a versatile imaging device known as VMS+ 3.0, which enhances cardiac imaging by using advanced data analytics and 3D modeling. This technology is designed to deliver more accurate and efficient cardiac assessments, supporting clinicians in diagnosing heart conditions with greater precision. VentriPoint Diagnostics' offerings are particularly impactful in areas where traditional imaging technologies fall short, such as in obtaining complete heart function information from 2D ultrasound images. By addressing these gaps, VentriPoint plays a crucial role in improving patient outcomes and optimizing healthcare resource utilization, making it a notable player in medical diagnostics.
About
CEO
Mr. Hugh MacNaught
Employees
0
Address
18 Hook Avenue
Unit 101
Toronto, M6P 1T4, ON
Canada
Unit 101
Toronto, M6P 1T4, ON
Canada
Phone
416 848 4156
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Medical Devices
Country
Canada
MIC code
NEOE